AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2015
Sep 16, 2015
31523_dirs_2015-09-16_30368d3a-0966-40e7-9322-1a6e5060003f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-09-15
Reporting Person: Do Hung (Chief Science Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-15 | Common Stock | S | 25000 | $17.7467 | Disposed | 720953 | Direct |
Footnotes
F1: The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2015.
F2: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $17.17 to $18.18. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.